Does the addition of chemotherapy to neoadjuvant radiotherapy impact survival in high-risk extremity/trunk soft-tissue sarcoma?

Keyphrases

• Trunk 100%
• High Risk 100%
• Chemotherapy 100%
• Neoadjuvant Radiotherapy 100%
• Soft Tissue Sarcoma 100%
• Chemoradiotherapy 100%
• Radiotherapy 83%
• Overall Survival 83%
• Confidence Interval 33%
• Hazard Ratio 33%
• Propensity Score Matching 33%
• Overall Survival Rate 33%
• Kaplan-Meier 33%
• Neoadjuvant Chemotherapy 33%
• Multivariable 16%
• National Cancer Database 16%
• Cox Proportional Hazards Model 16%
• Adult Patients 16%
• Kaplan-Meier Method 16%
• Log-rank Test 16%
• Treatment Selection Bias 16%
• Propensity Score Analysis 16%
• Matched Cohort 16%
• Limb Salvage 16%
• Potential Treatments 16%
• High-grade Tumor 16%
• Distant Recurrence 16%
• Random Data 16%

Medicine and Dentistry

• Soft Tissue Sarcoma 100%
• Radiation Therapy 100%
• Overall Survival 77%
• Chemoradiotherapy 66%
• Propensity Score Matching 33%
• Survival Rate 22%
• Hazard Ratio 22%
• Neoadjuvant Chemotherapy 22%
• Malignant Neoplasm 11%
• Base 11%
• Neoplasm 11%
• Recurrent Disease 11%
• Proportional Hazards Model 11%
• Selection Bias 11%
• Kaplan Meier Method 11%
• Log Rank Test 11%
• Limb Salvage 11%

Immunology and Microbiology

• Overall Survival 100%
• Soft Tissue 100%
• Trunk 100%
• Survival Rate 28%
• Limb 14%